secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2022-01-10T23:59:59+00:00
Accession:  0001380106-22-000003
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro Bio pre-announces Q4 rev $4.7-5.2M; FY22 outlook $27-32M
--------------------------------------------------------------------

- Preliminary Q4 total revenue $4.7M-$5.2M; commercial $4.5M-$4.9M; non-commercial (BARDA) $0.2M-$0.3M.
- Full year 2021 total revenue $22.8M-$23.3M; commercial $21.3M-$21.7M; placed 29 systems, validated 33.
- Recurring revenue grew ~90% in Q4 vs prior-year period; 16 systems validated in Q4.
- FY2022 commercial revenue outlook $27M-$32M, 25%-50% growth over preliminary FY2021 commercial revenue.
- Ended 2021 with >$200M cash and investments, zero debt; COVID headwinds impacted Q4 placements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010622000003/0001380106-22-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010622000003/c106-20220109x8k.htm
  HTML page:      https://secwatch.observer/filing/0001380106-22-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer